Device recall
Z-0111-04: DomiVisc Sodium Hyaluronate 0.8 mL 12 mg.mL Syringe. Sterile.RX. For intraocular…
FDA device recall · Class III · Anika Therapeutics
Key facts
| Recall number (Z-number) | Z-0111-04 |
|---|---|
| Recall event | 27457 |
| Product | DomiVisc Sodium Hyaluronate 0.8 mL 12 mg.mL Syringe. Sterile.RX. For intraocular use Product Numbner; P012-180A Manufactured for Bausch & Lomb |
| Product code | LZP |
| Recalling firm | Anika Therapeutics |
| Recall class | Class III |
| Status | Terminated |
| Termination date | Aug 9, 2004 |
| PMA numbers | P810025 |
| FEI number | 3007093114 |
At a glance
- None Linked 510(k)s
- 1–9 Products in the same recall event
- 10–99 Recalled products with this product code
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device recalls (products)
Each recalled device product receives a Z-number. Recall details such as root cause, distribution and firm actions are available in Orca1.
Source: U.S. Food and Drug Administration (FDA), Medical Device Recalls database